Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data.
about
Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@en
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@nl
type
label
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@en
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@nl
prefLabel
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@en
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@nl
P2093
P1476
Use of the JADAS criteria to a ...... alysis of 12-week pooled data.
@en
P2093
A Consolaro
HI Brunner
K Lheritier
N Wulffraat
P2860
P2888
P304
P356
10.1186/1546-0096-12-S1-P63
P433
P577
2014-09-17T00:00:00Z
P5875
P6179
1008152530